Clinical trial · Interventional
Emergency Department-based Cervical Cancer Screening Through Self-sampling
Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling
NCT07345897CI-TRIAL-00110226recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer (Early Detection) | Malignant Cervical Neoplasm | CURATED_EXACT | 0.85 |
| Cervical Cancer Screening | — | UNRESOLVED | — |
| HPV | — | UNRESOLVED | — |
| HPV Associated Cancers | — | UNRESOLVED | — |
| HPV Cancers | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cervical Cancer Screening | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention Arm
- description
- Participants will be provided the opportunity to self- sample for HPV during their ED visit. Participants will be (1) briefly instructed by study staff on how to self-sample using a defined instructional script written at an elementary reading level, (2) provided with a packaged swab, and (3) invited to self- sample privately in their ED room or in one of the private ED restrooms. Once self sampling has been completed, the study staff will then transfer the swab to a vial of transport media and forward the specimens to the laboratory for analysis. Participants recruited to the intervention arm that subsequently decline to or are unable to self-sample in the ED will remain in the study and will receive referral for clinic-based screening.
- interventionNames
- Diagnostic Test: Cervical Cancer Screening
Primary outcomes (1)
- measure
- Uptake of cervical cancer screening from self-sampling in the ED
- timeFrame
- In about 150 days of enrollment
- description
- Number of subjects referred for additional screening who follow through with next steps in the screening process.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * Cisgender women and transgender/non-binary individuals with a cervix, * Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known exclusion criteria present. Exclusion Criteria: * Past hysterectomy with cervical removal * Known infection with HIV (as screening recommendations for people with HIV differ from the general population) * Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress) * Current pregnancy or in the three months after giving birth * Use of vaginal ovules, creams or washes, vaginal contraceptives or condoms within past 3 days * Sexual intercourse or transvaginal ultrasound scans or gynecological examinations within past 2 days
References
Publications (0)
Data not yet available
No reference posted for this study.